How PSA biosynthesis is regulated in mammals -in particular the number of specific enzymatic activities involved in PSA production -is still an open question. Previous attempts to define the biosynthetic steps associated with PSA production led to divergent results, with respect to the PSA acceptor site and the number of potential enzymatic activities [16] [17] [18] . We therefore developed a new experimental strategy, in which NCAM variants isolated from glycosylation-defective mutant Chinese hamster ovary (CHO) cells [19] and soluble recombinant glycosyltransferases were used to reconstruct the site at which PST-1 acts to polysialylate NCAM in vitro.
NCAM and PSA are expressed on the surface of wild-type CHO cells; PSA-negative derivatives of these cells have been isolated using chemical mutagenesis. The PSAnegative phenotype of the complementation group 2A10 is the result of a defective PST-1 gene [14] . The CHO mutant 6B2 [20] , which belongs to the Lec2 complementation group, and Lec8 cells are defective in the Golgi transport systems for the activated nucleotide sugars CMP-sialic acid and UDP-galactose, respectively [19] . As a consequence, 6B2 cells express asialoglycans, and Lec8 cells express agalactoglycans [20, 21] , whereas 2A10 cells can synthesize the mature complex core oligosaccharides [14] . To determine whether these NCAM species could be modified by PST-1, cells were metabolically labelled, and 35 S-labelled NCAM ([ 35 S]NCAM) was isolated by immunoprecipitation using the H28 monoclonal antibody [22] . Glycosylation reactions were carried out with recombinant enzymes, in the presence of the activated sugar [24] , NCAM generated by endoNE digestion migrates more slowly than the PSA-negative forms of NCAM. Therefore, two double bands could be seen after endoNE treatment. The higher molecular weight bands disappeared after additional treatment of the sample with exoneuraminidase from Vibrio cholerae (data not shown).
Under identical assay conditions, the asialo-[ 35 S]NCAM isolated from 6B2 cells ( Fig. 1 ; lane 4) was not recognized as a substrate for PST-1 (lane 5). However, the acceptor structure could be reconstituted in vitro by the addition of ␣2,3-linked sialic acid (lane 6). Again the smeared band produced by PST-1 (lane 7) was sensitive to endoNE digestion (lane 8). These data clearly show that PST-1 is sufficient to polysialylate NCAM and suggest that terminal sialylation of the acceptor core oligosaccharide is a prerequisite for polysialylation.
Kitajima et al. [25] have suggested that specific sugar modifications within the distal parts of the PSA-containing N-glycan core structures provide recognition sites for the Brief Communication 1189 The scheme represents the minimal oligosaccharide structure of the NCAM molecule recognized by PST-1, and the composition of the polysialylated cores before and after endoNE treatment. The basic oligosaccharide structure up to GlcNAc is depicted as suggested by Finne and Mäkelä [24] . The terminal sialic acid in the PSA acceptor site can be bound via an ␣2,3 or ␣2,6 linkage to the ␤1,4-linked galactose. Addition of ␣2,8-linked sialic acids is the result of PST-1 activity. For the degradation of PSA, endoNE requires at least five residues on the proximal side and at least three on the distal side of the cleavage site [24] . Therefore, a minimum of five ␣2,8-linked sialic acids remain bound to the polysialylated branch, and cleaved products between three and seven residues long are released by endoNE. Gal, galactose; GlcNAc, N-acetylglucosamine; Neu5Ac, N-acetylneuraminic acid; Man, mannose; Fuc, fucose. Fig. 2a,b ; lanes 1-3); however, the consecutive addition of ␤1,4-linked galactose to N-acetylglucosamine (Gal␤1→4GlcNAc; Fig.  2a, lane 4) , and ␣2→3-linked N-acetylneuraminic acid to galactose (Neu5Ac␣2→3Gal; Fig. 2a, lane 5) , or Gal␤1→4GlcNAc ( Fig. 2b; lane 4) and Neu5Ac␣2→6Gal ( Fig. 2b ; lane 5) re-created the functional acceptor site for PSA modification. In both cases, incubation with PST-1 produced the typical PSA smear (Fig. 2a,b; lane 6) . The specificity of the reaction products was again confirmed by treatment with endoNE ( Fig. 2a,b; lane 7) . The successful and complete reconstitution in individual monoglycosyltransferase reactions is indicated by the characteristic shifts in the molecular weight of [ 35 S]NCAM ( Fig. 2a,b ; lanes 1, 4 and 5).
Taken together, these results unambiguously show that mature complex core oligosaccharides are sufficient for PST-1 to recognize and modify its substrate. The observation that PST-1 was equally active on ␣2,3-and ␣2,6-sialylated structures was rather unexpected (see Fig. 2a ,b; lane 6). Moreover, this finding contradicts an earlier study, in which the overexpression of ␣2,6-sialyltransferase in Xenopus laevis embryos was accompanied by an overall reduction in the PSA content, and dramatic alterations in the PSA distribution pattern [26] . An explanation for the different results may reside in the experimental systems employed. In contrast to the in vitro system used in our laboratory, these authors investigated the overexpression of ␣2,6-sialyltransferase in an adapted in vivo system [26] . Their results may therefore reflect secondary effects, rather than a direct inhibition of the Xenopus laevis polysialyltransferase by ␣2,6-sialylation. Figure 3 updates the model of PSA-containing core structures in the NCAM molecule. In accordance with a previous report [24] , our data show that the minimal acceptor site recognized by PST-1 is part of an asparagine-linked complex core. Priming of the core by terminally linked sialic acid is required, but PST-1 does not show specificity with respect to the catalytic start point. The first sialic acid can be linked to either the C3-or C6-position of the penultimate galactose, which in our experiments is ␤1,4 glycosidically linked to GlcNAc. 'Initiation' of the PSA chain by a separate ␣2,8-sialyltransferase, as suggested for PSA synthesis in Salmonidae [27] , can be excluded in the mammalian system.
Materials and methods

Materials
UDP-Gal:GlcNAc-R ␤1→4-galactosyltransferase (Gal-T; EC 2.4.1.90) and CMP-sialic acid:Gal␤1→4GlcNAc-R ␣2→6-sialyltransferase (␣2,6-ST; EC 2.4.99.1) were purchased from Boehringer Mannheim.
Recombinant CMP-sialic acid:Gal␤1→3(4)GlcNAc-R ␣2→3-sialyltransferase (␣2,3-ST; EC 2.4.99.6) [28] , was kindly donated by J. C. Paulson (Cytel Corporation, La Jolla, USA). EndoNE was purified from the Escherichia coli K1 bacteriophage, PK1E, as described [23] . Monoclonal antibody H28 (rat IgG2a) directed against mouse NCAM isoforms [22] was kindly provided by C. Goridis (CNRS, Marseille, France). The antibody was used after affinity purification on protein G-Sepharose (Pharmacia).
Cell culture
All cell lines were grown in ␣-MEM (Gibco) supplemented with 10 % FCS, 2 mM L-glutamine, 10 mM pyruvate, 100 U ml -1 penicillin and 100 U ml -1 streptomycin.
Construction and expression of soluble PST-1
A truncated, soluble form of PST-1 was constructed using the vector pPROTA (generously provided by R. Breathnach, IMSERM, Nantes, France) [29] . Nucleotides +377 to +1380 of the hamster cDNA [14] were amplified by PCR and cloned into pPROTA. The cloned fragment encompasses the coding sequence of PST-1, but lacks the first 26 amino acids, which contain the putative transmembrane region. The resulting plasmid pPROTA-PST-1, encodes a transin signal sequence and the IgG-binding domain of protein A in front of truncated PST-1.
Recombinant protein A-PST-1 was isolated from transiently transfected 2A10 cells. For transfection, 10 6 cells were plated onto 10 cm culture dishes and incubated for 18 h. Cells were rinsed three times with 5 ml PBS (phosphate buffered saline: 10 mM sodium phosphate (pH 7.4), 150 mM sodium chloride) and transfected with 4 g pPROTA-PST-1 and 24 l Lipofectamine in 5 ml OptiMEM (Gibco).
The transfection was stopped after 7 h by adding 5 ml ␣-MEM containing 20 % FCS; 24 h later, this medium was exchanged for 8 ml ␣-MEM containing 5 % FCS and cells cultured for another 48 h. Cell supernatants were harvested, concentrated ten-fold using Centricon-30 filters (Amicon), dialyzed against 10 mM sodium cacodylate (pH 6.5) and 10 mM MnCl 2 , and used as the soluble enzyme.
Immunoprecipitation of metabolically labelled NCAM
For metabolic labelling, 2 × 10 6 cells were grown overnight on 6 cm dishes. Cells were washed three times with methionine-free MEM (Gibco), and incubated for 1 h in 1 ml of the same medium, containing 10 % FCS (dialyzed overnight against PBS). [ 35 S]methionine (100 Ci; Amersham) was added and cells incubated for another 6 h. The labelling was stopped by rinsing the dishes twice with 2 ml PBS. Subsequently the cells were lysed on the plates by the addition of 1 ml ice-cold lysis buffer (50 mM Tris-HCl (pH 8.0), 1 % NP-40, 2 % CHAPS 10 mM EDTA, 1 mM MgCl 2 , 10 U ml -1 aprotinin and 1 mM PMSF). After centrifugation (14 500 × g; 5 min), 300 l aliquots of the supernatant were immunoprecipitated with 20 l of a 50 % suspension of monoclonal antibody H28 [22] covalently bound to protein G-Sepharose [30] . The precipitation was carried out at 4°C for 2 h. Precipitates were washed with 1 ml of a solution containing 50 mM Tris-HCl (pH 8.0) and 0.5 % NP-40, twice in the presence and twice in absence of 500 mM NaCl; in between washes, samples were centrifuged at 5000 × g for 30 sec. Finally, the NCAM-coated beads were washed twice in 1 ml of the buffer system required to perform the subsequent enzymatic treatment.
Enzymatic treatment of immunoprecipitated NCAM samples
Enzyme reactions to reconstitute the mature complex core oligosaccharide structures of NCAM were carried out on solid phase-bound, immunoprecipitated NCAM. In a final reaction volume of 50 l, incubations were performed at 37°C in a thermomixer (Eppendorf) at 1400 rpm. For the addition of ␤1-4-linked galactose to N-acetylglucosamine, which is the ultimate sugar residue in Lec8 cells, the reaction mixture contained 10 l of NCAM-coated Sepharose beads, 3 mU galactosyltransferase [EC 2.4.1.90] and 1.5 mM UDP-galactose (Boehringer Mannheim) in 20 mM Tris-HCl (pH 8.0). The reaction was incubated for 30 min and stopped by washing with PBS. The addition of sialic acid to the C3-or C6-position of ␤1,4-linked galactose, was carried out in 10 mM sodium cacodylate buffer containing 10 mM MnCl 2 at pH 6.5. Immunoprecipitated NCAM was incubated in presence of 1.6 mM CMP-Neu5Ac (Sigma) with 2 mU of ␣2,6-sialyltransferase [EC 2.4.1.90] and 6 mU of ␣2,3-sialyltransferase [EC 2.4.99.6], respectively. For polysialylation, the immunoprecipitates were incubated for 2 h in the presence of 1.6 mM CMP-Neu5Ac and 50 l of the concentrated, cacodylate-buffered cell-culture supernatant containing soluble protein A-PST-1. In order to specifically remove in vitro synthesized PSA from NCAM, the NCAM-coated beads were incubated for 1 h with 2 l (50 g ml -1 ) endoNE in PBS at 37°C.
SDS-PAGE and autoradiography
SDS-PAGE was performed according to Laemmli [31] on 7 % gels under reducing conditions. For autoradiographic development, gels were vacuum-dried and exposed for 14 days on Hyperfilm-MP (Amersham).
